Alkahest

Digital

pharmaphorum grabbed a moment with Alkahest Head of Data Science Benoit LeHallier after his talk at Frontiers Health.

R&D

Through a pioneering initiative called Chronos-PD, Grifols is partnering with the Michael J.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.